Imed and Ivac Join Forces
The deal couldn't have come too soon. For all the interest in IVAC and IMED, the infusion market is becoming increasingly competitive, with smaller companies slowly being squeezed out of the market by industry giants, Abbott and Baxter.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.